I just don't think it's a big deal, ... There certainly isn't any evidence linking Viagra with these reports. There is a risk with this form of blindness from diabetes and cardiovascular disease, and those are also risks for erectile dysfunction or impotence, which is also why people take Viagra.

I think it's sort of a meaningless statement from their perspective and they're trying to grab victory out of this by taking a posture that makes them look altruistic, ... I also think they're trying to look like they're being good corporate citizens. Since Bristol has been investigated by just about every government agency, they have a lot to make up for in that regard.

The market is under-penetrated, that's for sure.

I wouldn't say [Prozac] is selling well, ... It's nice that they preserved $182 million from the Prozac franchise, but it was $2 billion, so it's not real meaningful for Lilly.

We're left with a company with a litany of problems and a management that has zero credibility. I think some heads will roll and they will be very vulnerable to take-out.

Otherwise you are just creating a stalemate. Shareholders want to know who is going to be in charge.